Ropes & Gray has advised Sanofi, and Cooley has advised MapLight Therapeutics on the transaction. MapLight Therapeutics, a biotechnology company focused on developing therapeutics for central...
MapLight Therapeutics’ $372.5 Million Series D Financing
Blueprint Medicines Corporation’s Financing Collaborations with Sixth Street and Royalty Pharma
Goodwin Procter advised Blueprint Medicines Corporation on the deal while Cooley represented Sixth Street. Blueprint Medicines Corporation (NASDAQ: BPMC) announced its strategic financing collaborations with Sixth...


























